Concepedia

Allison M.L. Nixon

AM

9

Publications

899

Citations

9

H-Index

2005

Active since

Affiliations

University of Toronto(Current)

Princess Margaret Cancer Centre

Ontario Institute for Cancer Research

McMaster University

University Health Network

Allison M.L. Nixon is an author at University of Toronto specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2005–2022

9

Publications

9

Colorectal Cancer Cells Enter a Diapause-like DTP State to Survive Chemotherapy

Sumaiyah K. Rehman, Jennifer Haynes, Évelyne Collignon et al. · Cell · 2021 · 466 citations · Full text

, , +8

Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation

Anthony B. Mak, Allison M.L. Nixon, Saranya Kittanakom et al. · Cell Reports · 2012 · 181 citations · Full text

Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer

Robin Hallett, Maria Kondratyev, Andrew O. Giacomelli et al. · PLoS ONE · 2012 · 92 citations · Full text

The Mixed Lineage Leukemia (MLL) Fusion–Associated Gene <i>AF4</i> Promotes CD133 Transcription

Anthony B. Mak, Allison M.L. Nixon, Jason Moffat · Cancer Research · 2012 · 50 citations

, , +21

Post-Translational Regulation of CD133 by ATase1/ATase2-Mediated Lysine Acetylation

Anthony B. Mak, Mariana Pehar, Allison M.L. Nixon et al. · Journal of Molecular Biology · 2014 · 45 citations · Full text

, , +7

Rows per page

1–5 of 9